OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Yuqiong Xia, Lang Rao, Huimin Yao, et al.
Advanced Materials (2020) Vol. 32, Iss. 40
Closed Access | Times Cited: 668

Showing 1-25 of 668 citing articles:

Targeting ferroptosis as a vulnerability in cancer
Guang Lei, Li Zhuang, Boyi Gan
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 381-396
Open Access | Times Cited: 1282

Nanoparticles for Cancer Therapy: Current Progress and Challenges
Shreelaxmi Gavas, Sameer Quazi, Tomasz M. Karpiński
Nanoscale Research Letters (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 597

Macrophages in immunoregulation and therapeutics
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 576

Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 487

The blood–brain barrier: Structure, regulation and drug delivery
Di Wu, Qi Chen, Xiaojie Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 448

A Review on Metal- and Metal Oxide-Based Nanozymes: Properties, Mechanisms, and Applications
Yongyu Liu, Amin Zhang, Ruhao Wang, et al.
Nano-Micro Letters (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 396

Combination strategies to maximize the benefits of cancer immunotherapy
Shaoming Zhu, Tian Zhang, Lei Zheng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 387

Ferroptosis in the tumor microenvironment: perspectives for immunotherapy
Huanji Xu, Di Ye, Meiling Ren, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 9, pp. 856-867
Closed Access | Times Cited: 210

Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
Kun Cheng, Ning Cai, Jinghan Zhu, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1112-1140
Open Access | Times Cited: 186

Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment
Zijie Xu, Yi Chen, Ling Ma, et al.
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3133-3154
Open Access | Times Cited: 170

Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications
Joana Lopes, Daniela Lopes, Miguel Pereira‐Silva, et al.
Small Methods (2022) Vol. 6, Iss. 8
Open Access | Times Cited: 125

PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages
Lu Wang, Shuangshuang Li, Huanhua Luo, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 112

Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
Qindong Zhang, Mouldy Sioud
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7493-7493
Open Access | Times Cited: 112

Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment
Zhongyang Yu, Lei Gao, Kehan Chen, et al.
Nanoscale Research Letters (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 110

Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
Weiwei Zeng, Mian Yu, Ting Chen, et al.
Advanced Science (2022) Vol. 9, Iss. 23
Open Access | Times Cited: 109

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 109

Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Yanhui Zheng, Yaobao Han, Qiao Sun, et al.
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 108

LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Yihao Liu, Minmin Shi, Xingfeng He, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 102

Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Zhaoting Li, Yixin Wang, Yingyue Ding, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 23
Closed Access | Times Cited: 101

Hybrid‐Membrane‐Decorated Prussian Blue for Effective Cancer Immunotherapy via Tumor‐Associated Macrophages Polarization and Hypoxia Relief
Lin Hou, Xuan Gong, Jing Yang, et al.
Advanced Materials (2022) Vol. 34, Iss. 14
Closed Access | Times Cited: 95

Nanovaccines with cell-derived components for cancer immunotherapy
Zhouqi Meng, Yaojia Zhang, Xuanfang Zhou, et al.
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114107-114107
Closed Access | Times Cited: 81

Vaccine-like nanomedicine for cancer immunotherapy
Yunfei Yi, Mian Yu, Wen Li, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 760-778
Closed Access | Times Cited: 79

Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy
Wen Lei, Chen Yang, Yi Wu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 78

Page 1 - Next Page

Scroll to top